Liquidia
LQDA
26.68
+0.77
+2.97%
Liquidia
US · LQDA
#2623 by market cap
Listed 2018
26.68
+0.77
+2.97%
Live - 5344 symbols - heartbeat 132s ago
· 2026-10-08 08:39
Pre-market
26.77
+0.35%
After-hours
26.40
-1.05%
Overnight
26.60
-0.30%
- Market cap
- 2.39B
- P/E (TTM)i
- 19.06
- P/Bi
- 12.24
- EPSi
- -0.80
- Div yieldi
- 0.00%
- 52W posi
- 7%
Reader sentiment
Are you bullish or bearish on LQDA?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.86, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +1,031.18% YoY
Margins
- Gross margin
- 91.64%
- Operating margin
- -32.45%
- Net margin
- -43.53%
Key ratios & quality
- Enterprise valuei
- 2.39B
- Altman Z-Scorei
- 2.86
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.71M | 8.07M | 739.63K | 12.85M | 15.94M | 17.49M | 14.00M | 158.32M |
| Gross profit | 2.59M | 7.26M | 501.92K | 9.83M | 13.08M | 14.60M | 8.12M | 145.08M |
| Selling & admin expenses | 8.75M | 13.60M | 27.37M | 23.11M | 32.41M | 44.74M | 81.57M | 157.18M |
| Research & development | 28.70M | 40.49M | 32.22M | 20.52M | 19.44M | 43.24M | 47.84M | 39.28M |
| Operating profit | -34.87M | -46.82M | -59.09M | -33.80M | -38.77M | -73.38M | -121.29M | -51.38M |
| Pretax profit | -53.14M | -47.58M | -59.76M | -34.58M | -41.02M | -78.50M | -128.29M | -68.92M |
| Tax | -- | -- | -- | -- | -- | -- | -- | -- |
| Net profit | -53.14M | -47.58M | -59.76M | -34.58M | -41.02M | -78.50M | -128.29M | -68.92M |
| Basic EPS | -7 | -3 | -2 | -1 | -1 | -1 | -2 | -1 |
| Diluted EPS | -7.51 | -2.57 | -1.76 | -0.70 | -0.67 | -1.21 | -1.63 | -0.80 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 3.12M | 8.84M | 54.34M | 92.02M | 132.87M | 171.68M |
| Gross profit | 1.60M | 7.34M | 51.17M | 84.97M | 121.01M | 160.13M |
| Selling & admin expenses | 30.06M | 38.82M | 40.06M | 48.24M | 46.94M | 57.43M |
| Research & development | 6.97M | 6.02M | 9.35M | 16.94M | 12.57M | 17.18M |
| Operating profit | -35.43M | -37.51M | 1.77M | 19.79M | 61.50M | 85.52M |
| Pretax profit | -38.37M | -41.58M | -3.53M | 14.56M | 56.78M | 81.70M |
| Tax | 0 | 0 | -- | -- | 3.92M | 6.98M |
| Net profit | -38.37M | -41.58M | -3.53M | 14.56M | 52.86M | 74.72M |
| Basic EPS | 0 | 0 | 0 | 0 | 1 | 1 |
| Diluted EPS | -0.45 | -0.49 | -0.04 | 0.15 | 0.52 | 0.74 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 40.03M | 56.39M | 66.07M | 61.28M | 99.81M | 89.90M | 185.11M | 273.40M |
| Cash & ST investments | 39.53M | 55.80M | 65.32M | 57.49M | 93.28M | 83.68M | 176.48M | 190.68M |
| Inventory | -- | -- | -- | -- | -- | 0 | 241.00K | 23.80M |
| Total assets | 49.42M | 68.84M | 99.53M | 93.73M | 129.20M | 118.33M | 230.31M | 327.93M |
| Total current liabilities | 8.25M | 16.87M | 11.74M | 7.33M | 8.80M | 18.55M | 41.78M | 135.77M |
| Short-term debt | 769.61K | 7.40M | 1.59M | 1.09M | 1.08M | 3.75M | 18.43M | 58.89M |
| Long-term debt | 11.63M | 10.29M | 10.29M | 10.41M | 19.88M | 43.42M | 95.27M | 132.94M |
| Total liabilities | 30,730,587.00 | 33,894,520.00 | 28,445,922.00 | 28,464,000.00 | 38,776,000.00 | 71,039,000.00 | 150,935,000.00 | 283,186,000.00 |
| Total equity | 18.69M | 34.95M | 71.09M | 65.27M | 90.42M | 47.29M | 79.38M | 44.75M |
| Retained earnings | -167.05M | -215.24M | -275.00M | -309.58M | -350.60M | -429.10M | -557.39M | -626.31M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 177.21M | 195.58M | 226.72M | 273.40M | 333.06M | 437.71M |
| Cash & ST investments | 169.76M | 173.42M | 157.50M | 190.68M | 222.79M | 284.18M |
| Inventory | 1.35M | 6.44M | 24.53M | 23.80M | 28.51M | 36.18M |
| Total assets | 227.43M | 257.41M | 275.98M | 327.93M | 401.53M | 521.92M |
| Total current liabilities | 60.52M | 78.41M | 102.94M | 135.77M | 149.74M | 189.30M |
| Short-term debt | 38.00M | 44.54M | 56.48M | 58.89M | 51.03M | 54.85M |
| Long-term debt | 103.18M | 149.47M | 136.45M | 132.94M | 127.64M | 122.15M |
| Total liabilities | 177,716,000.00 | 242,222,000.00 | 253,929,000.00 | 283,186,000.00 | 292,954,000.00 | 326,804,000.00 |
| Total equity | 49.71M | 15.19M | 22.05M | 44.75M | 108.58M | 195.11M |
| Retained earnings | -595.76M | -637.34M | -640.87M | -626.31M | -573.45M | -498.73M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -31.83M | -48.28M | -54.14M | -34.04M | -28.59M | -41.56M | -93.42M | -35.69M |
| Depreciation & amortization | 1.54M | 2.57M | 3.13M | 5.61M | 3.65M | 2.18M | 2.20M | 1.53M |
| Free cash flow | -32.70M | -50.13M | -54.90M | -34.14M | -29.18M | -52.85M | -101.87M | -42.02M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 47.32M | 63.04M | 71.23M | 21.71M | 54.46M | 24.24M | 138.55M | 0 |
| Ending cash balance | 39.53M | 55.80M | 65.32M | 57.49M | 93.28M | 83.68M | 176.48M | 194.18M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -30.68M | -39.48M | -9.77M | 44.24M | 52.99M | 80.24M |
| Depreciation & amortization | 451.00K | 281.00K | 476.00K | 320.00K | 497.00K | 400.00K |
| Free cash flow | -31.01M | -40.54M | -10.68M | 40.21M | 50.16M | 68.01M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | 0 | -- | -- |
| Ending cash balance | 169.76M | 176.93M | 161.00M | 194.18M | 226.29M | 287.69M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | -177.43 | -112.72 | -50.72 | -52.69 | -114.01 | -209.35 | -112.97 |
| ROA %i | -165.37 | -80.47 | -70.99 | -35.78 | -36.80 | -63.43 | -74.80 | -24.69 |
| ROIC %i | -- | -103.11 | -80.07 | -39.86 | -40.53 | -91.37 | -100.26 | -23.23 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -101.51 | -106.54 | -106.21 |
| EBIT margin %i | -1,261.47 | -572.46 | -7,964.11 | -262.68 | -242.72 | -413.02 | -842.44 | -28.27 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Current ratioi | 4.85 | 3.34 | 5.63 | 8.36 | 11.34 | 4.85 | 4.43 | 2.01 |
| Quick ratioi | 4.83 | 3.31 | 5.56 | 8.25 | 11.17 | 4.73 | 4.29 | 1.80 |
| Debt / assetsi | 25.85 | 35.47 | 17.22 | 17.16 | 18.93 | 41.86 | 52.23 | 60.36 |
| LT debt / equityi | 64.23 | 48.70 | 21.88 | 22.97 | 25.86 | 96.81 | 128.32 | 310.70 |
| Interest coveragei | -1.80 | -33.64 | -68.65 | -41.43 | -16.54 | -11.51 | -9.44 | -1.85 |
| Revenue CAGR (3Y) %i | -- | -15.16 | -53.29 | 68.08 | 25.45 | 187.02 | 2.88 | 114.98 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -203.98 | -389.14 | -187.21 | -112.97 | 28.18 | 131.82 |
| ROA %i | -65.33 | -69.73 | -46.93 | -24.69 | 7.09 | 35.57 |
| ROIC %i | -92.16 | -101.33 | -66.70 | -23.23 | 13.82 | 50.56 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -881.53 | -700.05 | -150.94 | -28.27 | 18.13 | 39.06 |
| FCF / sales %i | -- | -- | -- | -- | 13.59 | 32.75 |
| Current ratioi | 2.93 | 2.49 | 2.20 | 2.01 | 2.22 | 2.31 |
| Quick ratioi | 2.83 | 2.34 | 1.88 | 1.80 | 1.98 | 2.07 |
| Debt / assetsi | 64.93 | 77.85 | 72.17 | 60.36 | 46.03 | 35.04 |
| LT debt / equityi | 220.59 | 1,026.08 | 647.12 | 310.70 | 123.22 | 65.63 |
| Interest coveragei | -8.91 | -8.29 | -5.33 | -1.85 | 2.01 | 6.61 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Product sales, net is the largest reported line at 99.24% of revenue, across 2 reported segments.
- The next-largest line, Service revenue, net, is a distant second at 0.76% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Product sales, net99.24%
Service revenue, net0.76%
Quote time 2026-10-08 08:39:24 · For reference only, not investment advice and not tailored to your situation.